{"id":"https://openalex.org/W2595201361","doi":"https://doi.org/10.2215/cjn.10180916","title":"Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function","display_name":"Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function","alternate_titles":[],"publication_year":2017,"publication_date":"2017-03-16","ids":{"openalex":"https://openalex.org/W2595201361","doi":"https://doi.org/10.2215/cjn.10180916","mag":"2595201361","pmid":"https://pubmed.ncbi.nlm.nih.gov/28302903","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5477216"},"language":"en","primary_location":{"id":"doi:10.2215/cjn.10180916","doi":"https://doi.org/10.2215/cjn.10180916","is_oa":true,"landing_page_url":"https://doi.org/10.2215/cjn.10180916","pdf_url":"https://cjasn.asnjournals.org/content/clinjasn/12/5/751.full.pdf","source":{"id":"https://openalex.org/S184267533","display_name":"Clinical Journal of the American Society of Nephrology","issn_l":"1555-9041","issn":["1555-9041","1555-905X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Journal of the American Society of Nephrology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2595201361"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://cjasn.asnjournals.org/content/clinjasn/12/5/751.full.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017802426","display_name":"Sergei I. Petrykiv","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Sergei Petrykiv","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041913215","display_name":"C. David Sj\u00f6str\u00f6m","orcid":"https://orcid.org/0000-0002-8380-9766","observed_orcids":["https://orcid.org/0000-0002-8380-9766"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. David Sj\u00f6str\u00f6m","raw_affiliation_strings":["AstraZeneca Gothenburg, M\u00f6lndal, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Gothenburg, M\u00f6lndal, Sweden;","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020663562","display_name":"Peter J. Greasley","orcid":"https://orcid.org/0000-0002-2529-4477","observed_orcids":["https://orcid.org/0000-0002-2529-4477"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter J. Greasley","raw_affiliation_strings":["AstraZeneca Gothenburg, M\u00f6lndal, Sweden;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Gothenburg, M\u00f6lndal, Sweden;","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040311049","display_name":"John L. Xu","orcid":"https://orcid.org/0009-0002-7173-4901","observed_orcids":["https://orcid.org/0009-0002-7173-4901"]},"institutions":[{"id":"https://openalex.org/I4210150756","display_name":"AstraZeneca (United States)","ror":"https://ror.org/043cec594","country_code":"US","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210150756"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Xu","raw_affiliation_strings":["AstraZeneca, Gaithersburg, Maryland; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Gaithersburg, Maryland; and","institution_ids":["https://openalex.org/I4210150756"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012676820","display_name":"Frederik Persson","orcid":"https://orcid.org/0000-0001-6242-6638","observed_orcids":["https://orcid.org/0000-0001-6242-6638"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Frederik Persson","raw_affiliation_strings":["Steno Diabetes Center, Gentofte, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Steno Diabetes Center, Gentofte, Denmark","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5031624913","display_name":"Hiddo J.L. Heerspink","orcid":"https://orcid.org/0000-0002-3126-3730","observed_orcids":["https://orcid.org/0000-0002-3126-3730"]},"institutions":[{"id":"https://openalex.org/I1334415907","display_name":"University Medical Center Groningen","ror":"https://ror.org/03cv38k47","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I1334415907"]},{"id":"https://openalex.org/I169381384","display_name":"University of Groningen","ror":"https://ror.org/012p63287","country_code":"NL","type":"education","lineage":["https://openalex.org/I169381384"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Hiddo J.L. Heerspink","raw_affiliation_strings":["Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;","institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5017802426","https://openalex.org/A5031624913"],"corresponding_institution_ids":["https://openalex.org/I1334415907","https://openalex.org/I169381384"],"apc_list":null,"apc_paid":null,"fwci":15.0491,"has_fulltext":true,"cited_by_count":160,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.9950846,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":100},"biblio":{"volume":"12","issue":"5","first_page":"751","last_page":"759"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sglt2-inhibitors","display_name":"SGLT2 inhibitors","score":0.9350000023841858},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.8830000162124634},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.7269999980926514},{"id":"https://openalex.org/keywords/estimated-glomerular-filtration-rate","display_name":"estimated glomerular filtration rate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.7950000166893005},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7419999837875366},{"id":"https://openalex.org/keywords/albuminuria","display_name":"albuminuria","score":0.8289999961853027},{"id":"https://openalex.org/keywords/albumin-creatinine-ratio","display_name":"albumin-creatinine ratio","score":0.9419999718666077},{"id":"https://openalex.org/keywords/blood-pressure","display_name":"blood pressure","score":0.7749999761581421},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.9810000061988831},{"id":"https://openalex.org/keywords/hematocrit","display_name":"hematocrit","score":0.996999979019165},{"id":"https://openalex.org/keywords/sodium-excretion","display_name":"sodium excretion","score":0.7990000247955322},{"id":"https://openalex.org/keywords/osmotic-diuresis","display_name":"osmotic diuresis","score":0.9459999799728394},{"id":"https://openalex.org/keywords/cardiovascular-risk-factors","display_name":"cardiovascular risk factors","score":0.8090000152587891},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7860000133514404}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9197032451629639},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.7248936891555786},{"id":"https://openalex.org/C2777422806","wikidata":"https://www.wikidata.org/wiki/Q409898","display_name":"Dapagliflozin","level":4,"score":0.7020263671875},{"id":"https://openalex.org/C3019921246","wikidata":"https://www.wikidata.org/wiki/Q104853310","display_name":"Differential effects","level":2,"score":0.46616631746292114},{"id":"https://openalex.org/C93226319","wikidata":"https://www.wikidata.org/wiki/Q193137","display_name":"Differential (mechanical device)","level":2,"score":0.4584481418132782},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.43929415941238403},{"id":"https://openalex.org/C14036430","wikidata":"https://www.wikidata.org/wiki/Q3736076","display_name":"Function (biology)","level":2,"score":0.4369809925556183},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3667908310890198},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.32925546169281006},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2983490228652954},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.25356918573379517},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.08759281039237976},{"id":"https://openalex.org/C78458016","wikidata":"https://www.wikidata.org/wiki/Q840400","display_name":"Evolutionary biology","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C146978453","wikidata":"https://www.wikidata.org/wiki/Q3798668","display_name":"Aerospace engineering","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077203","descriptor_name":"Sodium-Glucose Transporter 2 Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D000419","descriptor_name":"Albuminuria","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D001559","descriptor_name":"Benzhydryl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005919","descriptor_name":"Glomerular Filtration Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005960","descriptor_name":"Glucosides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006454","descriptor_name":"Hemoglobins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D007687","descriptor_name":"Kidney Tubules, Proximal","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051297","descriptor_name":"Sodium-Glucose Transporter 2","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D065840","descriptor_name":"Protective Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.2215/cjn.10180916","doi":"https://doi.org/10.2215/cjn.10180916","is_oa":true,"landing_page_url":"https://doi.org/10.2215/cjn.10180916","pdf_url":"https://cjasn.asnjournals.org/content/clinjasn/12/5/751.full.pdf","source":{"id":"https://openalex.org/S184267533","display_name":"Clinical Journal of the American Society of Nephrology","issn_l":"1555-9041","issn":["1555-9041","1555-905X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Journal of the American Society of Nephrology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4857069","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5477216","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5477216","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5477216/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin J Am Soc Nephrol","raw_type":"Text"},{"id":"pmid:28302903","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28302903","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical journal of the American Society of Nephrology : CJASN","raw_type":"Journal Article"},{"id":"pmh:oai:pure.rug.nl:openaire/3ed3a2de-2044-41b9-9e23-b2fb135ec104","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/3ed3a2de-2044-41b9-9e23-b2fb135ec104","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Petrykiv, S, Sjostrom, C D, Greasley, P J, Xu, J, Persson, F & Heerspink, H J L 2017, 'Differential Effects of Dapagliflozin on Cardiovascular Risk Factors at Varying Degrees of Renal Function', Clinical Journal of the American Society of Nephrology, vol. 12, no. 5, pp. 751-759. https://doi.org/10.2215/CJN.10180916","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:rug:oai:pure.rug.nl:publications/3ed3a2de-2044-41b9-9e23-b2fb135ec104","doi":null,"is_oa":true,"landing_page_url":"https://research.rug.nl/en/publications/3ed3a2de-2044-41b9-9e23-b2fb135ec104","pdf_url":null,"source":{"id":"https://openalex.org/S4306400420","display_name":"University of Groningen research database (University of Groningen / Centre for Information Technology)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I169381384","host_organization_name":"University of Groningen","host_organization_lineage":["https://openalex.org/I169381384"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clinical Journal of the American Society of Nephrology, 12(5), 751 - 759. AMER SOC NEPHROLOGY","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2215/cjn.10180916","doi":"https://doi.org/10.2215/cjn.10180916","is_oa":true,"landing_page_url":"https://doi.org/10.2215/cjn.10180916","pdf_url":"https://cjasn.asnjournals.org/content/clinjasn/12/5/751.full.pdf","source":{"id":"https://openalex.org/S184267533","display_name":"Clinical Journal of the American Society of Nephrology","issn_l":"1555-9041","issn":["1555-9041","1555-905X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Journal of the American Society of Nephrology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6433152044","display_name":null,"funder_award_id":"SDCC 3.A Complications","funder_id":"https://openalex.org/F4320318293","funder_display_name":"Steno Diabetes Center Copenhagen"}],"funders":[{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320318293","display_name":"Steno Diabetes Center Copenhagen","ror":"https://ror.org/03gqzdg87"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2595201361.pdf","grobid_xml":"https://content.openalex.org/works/W2595201361.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1945685354","https://openalex.org/W1953840628","https://openalex.org/W1973240292","https://openalex.org/W2030192134","https://openalex.org/W2038880847","https://openalex.org/W2054361323","https://openalex.org/W2075044961","https://openalex.org/W2076506641","https://openalex.org/W2077636750","https://openalex.org/W2081510795","https://openalex.org/W2092349330","https://openalex.org/W2097168611","https://openalex.org/W2101865653","https://openalex.org/W2108588975","https://openalex.org/W2108595845","https://openalex.org/W2114031829","https://openalex.org/W2114276479","https://openalex.org/W2122077393","https://openalex.org/W2123984464","https://openalex.org/W2138245361","https://openalex.org/W2146264128","https://openalex.org/W2150855258","https://openalex.org/W2152413054","https://openalex.org/W2153839551","https://openalex.org/W2154525074","https://openalex.org/W2167245776","https://openalex.org/W2169211121","https://openalex.org/W2169842872","https://openalex.org/W2257723432","https://openalex.org/W2284028653","https://openalex.org/W2417430601","https://openalex.org/W2418756187","https://openalex.org/W2424539745","https://openalex.org/W2425017047","https://openalex.org/W2436309489","https://openalex.org/W2492672367"],"related_works":["https://openalex.org/W2611243195","https://openalex.org/W2750589886","https://openalex.org/W4306319923","https://openalex.org/W3154959553","https://openalex.org/W2982125719","https://openalex.org/W2794310633","https://openalex.org/W3035132934","https://openalex.org/W2418756187","https://openalex.org/W2282647732","https://openalex.org/W2990818893"],"abstract_inverted_index":{"Background":[0],"and":[1,17,81,128,148,169,184,233,256],"objective":[2],"Sodium":[3],"glucose":[4],"cotransporter":[5],"2":[6,104,117,126,134],"inhibition":[7],"with":[8,85,102,138,143,192,267],"dapagliflozin":[9,40,91,144,164,243,250,285],"decreases":[10,252],"hemoglobin":[11],"A1c":[12],"(HbA1c),":[13],"body":[14,77,167,253],"weight,":[15,78,168,254],"BP,":[16,79,255],"albuminuria":[18],"(urinary":[19],"albumin-to-creatinine":[20,83,195,203,258],"ratio).":[21],"Dapagliflozin":[22],"also":[23],"modestly":[24],"increases":[25],"hematocrit,":[26,80,166,274],"likely":[27],"related":[28,181],"to":[29,107,111,120,182],"osmotic":[30],"diuresis/natriuresis.":[31],"Prior":[32],"studies":[33],"suggest":[34,280],"that":[35,178,281],"the":[36,208,223,268,282],"HbA1c\u2013lowering":[37,240],"effects":[38,46,179,241,264,272,283],"of":[39,67,163,174,242,261,270,284],"attenuate":[41],"at":[42,52],"lower":[43,154],"eGFR.":[44,262],"However,":[45,249],"on":[47,165,273],"other":[48],"cardiovascular":[49],"risk":[50],"factors":[51],"different":[53],"eGFR":[54,109,155,187,210,225],"levels":[55],"are":[56,186,286],"incompletely":[57],"understood.":[58],"Design,":[59],"setting,":[60],"participants,":[61],"&":[62],"measurements":[63],"This":[64],"pooled":[65],"analysis":[66],"11":[68],"phase":[69],"3":[70],"clinical":[71],"trials":[72],"assessed":[73],"changes":[74],"in":[75,100,141,201,207,222,265],"HbA1c,":[76],"urinary":[82,194,202,257],"ratio":[84,196,204,259],"placebo":[86,234],"(":[87,94,157,212],"n":[88,95],"=2178)":[89],"or":[90],"10":[92],"mg":[93],"=2226)":[96],"over":[97],"24":[98],"weeks":[99],"patients":[101],"type":[103],"diabetes":[105],"according":[106],"baseline":[108,175,193],"(eGFR\u226545":[110],"<60":[112],"ml/min":[113,122,130],"per":[114,123,131],"1.73":[115,124,132],"m":[116,125,133],",":[118,127],"eGFR\u226560":[119],"<90":[121],"eGFR\u226590":[129],").":[135],"Results":[136],"Compared":[137],"placebo,":[139],"reductions":[140,200],"HbA1c":[142],"were":[145,171,205],"0.6%,":[146],"0.5%,":[147],"0.3%,":[149],"respectively,":[150],"for":[151,230,277],"each":[152],"consecutive":[153],"subgroup":[156,211],"P":[158,213],"value":[159,214],"interaction":[160,215],"<0.001).":[161,216],"Effects":[162],"BP":[170],"similar":[172,271],"regardless":[173,260],"eGFR,":[176],"suggesting":[177],"potentially":[180],"volume":[183,278],"natriuresis":[185],"independent.":[188],"Moreover,":[189],"among":[190],"individuals":[191],"\u226530":[197],"mg/g,":[198],"placebo-adjusted":[199],"larger":[206],"lowest":[209,224],"Adverse":[217],"events":[218],"occurred":[219],"more":[220],"frequently":[221],"subgroup;":[226],"this":[227],"was":[228],"true":[229],"both":[231],"dapagliflozin-":[232],"-":[235],"treated":[236],"patients.":[237],"Conclusions":[238],"The":[239],"decrease":[244],"as":[245],"renal":[246],"function":[247],"declines.":[248],"consistently":[251],"These":[263],"conjunction":[266],"finding":[269],"a":[275],"proxy":[276],"contraction,":[279],"partly":[287],"mediated":[288],"via":[289],"nonglucosuric-dependent":[290],"mechanisms.":[291]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2595201361","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":10},{"year":2023,"cited_by_count":20},{"year":2022,"cited_by_count":13},{"year":2021,"cited_by_count":19},{"year":2020,"cited_by_count":21},{"year":2019,"cited_by_count":28},{"year":2018,"cited_by_count":30},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2017-03-23T00:00:00"}
